DiaSorin SpA says a new Rapid Response Diagnostic Test for COVID-19 yields sample-to-answer results in 60 minutes vs. current 5 to 7 hours.
Claims availability with CE mark and submitted to FDA approval by late March 2020:

https://uk.reuters.com/article/brief...-idUKFWN2B21CB